Literature DB >> 12096964

Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients.

Carol L Shields1, Jacqueline Cater, Jerry A Shields, Aning Chao, Hatem Krema, Miguel Materin, Luther W Brady.   

Abstract

OBJECTIVE: To evaluate tumor control and treatment complications following plaque radiotherapy combined with transpupillary thermotherapy for choroidal melanoma.
DESIGN: Prospective noncomparative interventional case series. INTERVENTION: All patients received treatment for choroidal melanoma using plaque radiotherapy followed by 3 sessions of transpupillary thermotherapy provided at plaque removal and at 4-month intervals. PARTICIPANTS: Two hundred seventy patients with newly diagnosed choroidal melanoma. MAIN OUTCOME MEASURES: The 2 main outcome measures included local tumor recurrence and treatment-related complications. The clinical data regarding patient features, tumor features, radiotherapy and thermotherapy parameters were analyzed for their effect on the 2 main outcomes using Cox proportional hazards regression models.
RESULTS: Prior to treatment, the median base of the tumor was 11 mm (range, 4-21 mm) and the median thickness was 4 mm (range, 2-9 mm). Most tumors were located in the posterior pole with a median proximity of 2 mm to the foveola and 2 mm to the optic disc. The median radiotherapy dose to the tumor apex was 9000 rad. Transpupillary thermotherapy was applied in 3 sessions at 4-month intervals for a median of 700 mW. The tumor decreased in thickness to a median of 2.3 mm by 1 year and 2.1 mm by 2 years' follow-up with stable findings thereafter. Using Kaplan-Meier estimates, tumor recurrence was 2% at 2 years and 3% at 5 years. Risk factors for tumor recurrence included macular location of the tumor epicenter (P =.03), diffuse tumor configuration (P =.005), and tumor margin extending underneath the foveola (P =.001). Using Kaplan-Meier estimates, treatment-related complications at 5 years included maculopathy in 18% of the participants, papillopathy in 38%, macular retinal vascular obstruction in 18%, vitreous hemorrhage in 18%, rhegmatogenous retinal detachment in 2%, cataract in 6%, and neovascular glaucoma in 7%. Enucleation for radiation complications was necessary in 3 cases (1%).
CONCLUSION: Plaque radiotherapy combined with transpupillary thermotherapy provides excellent local tumor control with only 3% recurrence at 5 years' follow-up.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12096964     DOI: 10.1001/archopht.120.7.933

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  30 in total

Review 1.  Lasers for the treatment of intraocular tumors.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2013-05       Impact factor: 3.161

2.  Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with Ruthenium-106 plaque radiotherapy.

Authors:  Agnieszka Kubicka-Trząska; Izabella Karska-Basta; Piotr Oleksy; Bożena Romanowska-Dixon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

3.  Combined brachytherapy and transpupillary thermotherapy for large choroidal melanoma: tumor regression and early complications.

Authors:  Klaus-Martin Kreusel; Nikolaos Bechrakis; Juliane Riese; Lothar Krause; Joachim Wachtlin; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

Review 4.  Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Authors:  Patrick Oellers; Prithvi Mruthyunjaya
Journal:  Melanoma Manag       Date:  2016-02-17

5.  Ruthenium-106 plaque radiotherapy alone or in combination with transpupillary thermotherapy in the management of choroidal melanoma.

Authors:  Kaan Gündüz; Rengin Aslihan Kurt; Hale Elif Akmeşe; Kenan Köse; Omür Uçakhan-Gündüz
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

6.  Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.

Authors:  Jonathan E Lu; R Joel Welch; Kavita K Mishra; Inder K Daftari; Susanna S Park
Journal:  Eye (Lond)       Date:  2019-07-05       Impact factor: 3.775

7.  [Transpupillary thermotherapy (TTT) for uveal melanomas. Long term results of a single TTT with an adapter for a conventional infrared laser].

Authors:  G Langmann; H Lechner; E Wenzel; G Mossböck; W Wackernagel
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

8.  Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments.

Authors:  Devron H Char; Riley Bove; Theodore L Phillips
Journal:  Trans Am Ophthalmol Soc       Date:  2003

9.  Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience.

Authors:  Y M Bartlema; J A Oosterhuis; J G Journée-De Korver; R E Tjho-Heslinga; J E E Keunen
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

10.  Cataract development in patients treated with proton beam therapy for uveal melanoma.

Authors:  Ira Seibel; Dino Cordini; Annette Hager; Aline I Riechardt; Matus Rehak; Alexander Böker; Dirk Böhmer; Jens Heufelder; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-26       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.